Home
>
National Drug Code (NDC)
>
ABILIFY
ABILIFY - 55154-2021-7 - (ARIPIPRAZOLE)
Drug Information of ABILIFY
| Product NDC: | 55154-2021 |
| Proprietary Name: | ABILIFY |
| Non Proprietary Name: | ARIPIPRAZOLE |
| Active Ingredient(s): | 10 mg/1 & nbsp; ARIPIPRAZOLE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ABILIFY
| Product NDC: | 55154-2021 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021436 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20021115 |
Package Information of ABILIFY
| Package NDC: | 55154-2021-7 |
| Package Description: | 14 TABLET in 1 BLISTER PACK (55154-2021-7) |
NDC Information of ABILIFY
| NDC Code | 55154-2021-7 |
| Proprietary Name | ABILIFY |
| Package Description | 14 TABLET in 1 BLISTER PACK (55154-2021-7) |
| Product NDC | 55154-2021 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ARIPIPRAZOLE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20021115 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | ARIPIPRAZOLE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
